Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003102 |
---|---|
Receipt number | R000003678 |
Scientific Title | Phase I-II Study of Irinotecan and Erlotinib in Patients with Erlotinib Failure for Non-Small Cell Lung Cancer |
Date of disclosure of the study information | 2010/01/27 |
Last modified on | 2019/02/04 14:37:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/01/27 11:31:38 | ||
2 | Update | 2011/01/27 15:54:44 | Interventions/Control_1 |
|
3 | Update | 2012/01/04 17:31:48 | Organization Division name Address Organization Division name Name of person sending information Name of person sending information Organization Organization Division name Address Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Email1 |
|
4 | Update | 2014/10/04 20:29:30 | Email Address Address |
|
5 | Update | 2015/07/27 09:05:26 | Recruitment status |
|
6 | Update | 2018/06/14 12:43:47 | Name of primary person or sponsor Organization Email1 |
|
7 | Update | 2019/02/04 14:37:30 | Recruitment status |